Advertisements
Tirzepatide
| Price: | US$ 100 |
|---|---|
| Minimum Order: | |
| Payment Terms: | Bank transfer,Bitcoin，USDT， Dogecoin |
| Port of Export: |
Product Details
| Model No.: | Brand Name: |
|---|
| Certification: | |
|---|---|
| Specification: | mg |
Packaging & Delivery
| Packaging: | |
|---|---|
| Delivery/Lead Time: | |
| Production Capacity: |
Product Description
Tirzepatide is a newly developed investigational drug approved by the FDA for the treatment of type 2 diabetes. It belongs to a class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists.
The design of Tirzepatide aims to enhance blood glucose levels and metabolic regulation by modulating the GIP and GLP-1 pathways. By activating GIP and GLP-1 receptors, Tirzepatide is intended to increase insulin secretion and reduce glucagon release, thereby improving glycemic control. Additionally, it has demonstrated significant weight loss effects, making it a highly promising treatment option, especially for obese patients, particularly those with type 2 diabetes.
|
SUPPLIER PROFILE
|
|||
|---|---|---|---|
| Company: | Aea.ltd | ||
| City/State | Hongkong, | Country: |
China 
|
| Business Type: | Export/Import - Trading Company | Established: | NA |
| Member Since: | 2024 | Contact Person | Vicky Liu |
SUPPLIER PROFILE
City/State/Country -
Hongkong,
China
Business Type -
Export/Import - Trading Company
Established -
NA
Member Since -
2024
Contact Person -
Vicky Liu